EP3353204
BI-SPECIFIC ANTI-VEGF/DLL4 ANTIBODY FOR USE IN TREATING PLATINUM-RESISTANT OVARIAN CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.9.2016EP published:
18.10.2023EP application number:
16849686.7
EPO information:
European Patent Register
Max expiry date:
22.9.2036
Title in English:
BI-SPECIFIC ANTI-VEGF/DLL4 ANTIBODY FOR USE IN TREATING PLATINUM-RESISTANT OVARIAN CANCERLanguage of the patent:
English
Timeline
Today
23.9.2016EP application
18.10.2023EP Publication
Owner
Name:
Mereo BioPharma 5, Inc.Address:
800 W El Camino Real Suite 180, Mountain View, CA 94040, US
Inventor
Name:
DUPONT, JakobAddress:
Hillsborough, California 94010, US
Name:
PARMAR, HemaAddress:
San Mateo, California 94403, US
Name:
STAGG, Robert JosephAddress:
Moraga, California 94556, US
Priority
Number:
201562222505 PDate:
23.9.2015Country:
US
Classification
Categories:
C07K 16/22, C07K 16/28, C07K 16/46, A61K 31/282, A61K 39/395